A small fragment of factor B as a potential inhibitor of complement alternative pathway activity |
| |
Authors: | Enas Yasser Sultan Dina Eid Rizk Hany Ibrahim Kenawy Ramadan Hassan |
| |
Institution: | Department of Microbiology & Immunology, Faculty of Pharmacy, Mansoura University, Egypt |
| |
Abstract: | BackgroundThe complement system is a key player in innate immunity and a modulator of the adaptive immune system. Among the three pathways of complement, the alternative pathway (AP) accounts for most of the complement activation. Factor B (FB) is a major protease of the AP, making it a promising target to inhibit the AP activity in conditions of uncontrolled complement activation.MethodsBased on the data obtained from sequence analysis and conformational changes associated with FB, we expressed and purified a recombinant FB fragment (FBfr). We tested the inhibitory activity of the protein against the AP by in vitro assays.ResultsFBfr protein was proven to inhibit the complement AP activity when tested by C3b deposition assay and rabbit erythrocyte hemolytic assay.ConclusionOur recombinant FBfr was able to compete with the native human FB, which allowed it to inhibit the AP activity. This novel compound is a good candidate for further characterization and testing to be used in complement diagnostic tests and as a drug lead in the field of complement therapeutics. |
| |
Keywords: | Complement Alternative pathway Factor B FBfr C3b deposition |
本文献已被 ScienceDirect 等数据库收录! |